A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204)

NCT03144674 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Incyte Corporation